Key Points

Tamil Nadu's Health Secretary has confirmed strict action against Sresan Pharmaceuticals following cough syrup-linked deaths in Madhya Pradesh. The company's license has been suspended and intensive inspections ordered across the state. Meanwhile, the Supreme Court rejected a petition demanding a CBI investigation into the tragedy. Madhya Pradesh police have already arrested the pharmaceutical company's owner in connection with the case.

Key Points: TN Health Secy Senthil Kumar on Sresan Pharma Cough Syrup Deaths

  • Sresan Pharmaceuticals owner arrested from Tamil Nadu over 20 child deaths in MP
  • TN government conducting intensive inspections across all pharmaceutical companies
  • Company fined earlier for safety violations and now license suspended
  • Supreme Court dismissed PIL seeking CBI probe into cough syrup deaths
3 min read

Govt conducting periodic inspections, taking follow-up action: TN Health Secy on death linked to cough syrup in MP

Tamil Nadu Health Secretary addresses cough syrup deaths in MP, reveals Sresan Pharma license suspended and 90 new drug inspectors recruited for stricter monitoring.

"The company's license has been suspended. Recently, the government has recruited 90 drug inspectors. - Senthil Kumar"

Chennai, October 10

Tamil Nadu Health Secretary Senthil Kumar expressed concern on Friday over the recent deaths linked to the consumption of cough syrup in Madhya Pradesh, stating that the state government has strengthened its monitoring mechanism for pharmaceutical companies, including Kanchipuram-based Sresan Pharmaceuticals. He added that for earlier lapses, necessary action had already been taken against the firm.

The Health Secretary's statement came after Madhya Pradesh Police arrested the owner of Sresan Pharmaceuticals from Tamil Nadu, in connection with the deaths of 20 children in the state, allegedly caused by the consumption of Coldrif cough syrup manufactured by the company.

Speaking to reporters, Senthil Kumar said that intensive inspections have been ordered across Tamil Nadu and strict measures have been taken against the company, which was found "violating safety norms".

"The state authority had done an inspection on this firm (Sresan Pharmaceuticals) and follow-up action of a fine was levied. In the last two years, there was a lapse for which action has been taken. The government has been conducting periodic inspections and taking follow-up action. Intensive inspections have been ordered in the state," he said.

Referring to the recent Comptroller and Auditor General (CAG) report that highlighted gaps in the state's drug testing process, the Health Secretary said, "Several violations have been reported, and criminal action is being taken. The company's (Sresan Pharmaceuticals) license has been suspended. Recently, the government has recruited 90 drug inspectors."

Earlier in the day, the Supreme Court dismissed a Public Interest Litigation (PIL) seeking a Central Bureau of Investigation (CBI) probe into the deaths of children in Madhya Pradesh and Rajasthan following the consumption of toxic cough syrup.

A bench headed by Chief Justice of India BR Gavai declined to entertain the plea after a brief hearing. Advocate Vishal Tiwari, the petitioner, argued that this was not the first instance of adulterated medicines being sold and said that a single agency investigation was required as states were "blaming each other."

Solicitor General Tushar Mehta, who was present in the courtroom, informed the bench that the state governments of Tamil Nadu and Madhya Pradesh, etc., were already taking necessary steps.

Tiwari further contended that several children had died and that no proper lab tests or clinical trials had been conducted.

Meanwhile, on Thursday, Madhya Pradesh police arrested S Ranganathan, the owner of the Tamil Nadu-based pharmaceuticals company that manufactured the Coldrif cough syrup linked to 20 children's deaths.

- ANI

Share this article:

Reader Comments

R
Rohit P
At least they're taking action now. Hiring 90 new drug inspectors is a good step. But why wait for tragedies to happen? Regular monitoring should be the norm, not an afterthought. Hope this brings some justice to the affected families.
A
Arjun K
The CAG report already highlighted gaps in drug testing. Why weren't these issues addressed earlier? This shows systemic failure in our regulatory mechanisms. We need better accountability at all levels.
S
Sarah B
As a mother, this terrifies me. We trust medicines to heal our children, not harm them. The company owner should face maximum punishment. Hope the government's new measures actually make a difference.
V
Vikram M
Good that the Supreme Court dismissed the PIL. States are capable of handling this. Tamil Nadu government seems to be taking appropriate steps - suspending license, conducting inspections. Let's give them a chance to fix the system.
K
Karthik V
This is why we need stronger pharmaceutical regulations across India. One state's negligence affects others. Maybe a central monitoring system would help prevent such tragedies. My prayers with the families who lost their children 🙏

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50